Sacubitril/valsartan research in chronic kidney disease from 2013 to 2025 demonstrated sustained growth in cardiorenal applications, while identifying gaps in long-term safety and dialysis dosing.
Research publications on sacubitril/valsartan in chronic kidney disease from 2013 to 2025
This bibliometric analysis maps the evolving research landscape of sacubitril/valsartan in CKD, highlighting a shift towards cardiorenal applications and identifying areas needing further study.
This bibliometric analysis delineates the evolving research landscape of sacubitril/valsartan in CKD from 2013 to 2025, highlighting sustained growth, key contributors, and emerging research themes. The findings underscore increasing attention to cardiorenal applications, precision medicine, and combination therapies, while also identifying persistent gaps related to long-term safety, dialysis dosing, and renoprotective mechanisms. These insights provide a structured reference to inform future clinical and translational research in CKD.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peihan Liu
Xueqin He
Xinyao Luo
Renal Failure
Sichuan University
West China Hospital of Sichuan University
People's Hospital of Xinjiang Uygur Autonomous Region
Building similarity graph...
Analyzing shared references across papers
Loading...
Liu et al. (Tue,) conducted a other in Chronic kidney disease. Sacubitril/valsartan was evaluated. Sacubitril/valsartan research in chronic kidney disease from 2013 to 2025 demonstrated sustained growth in cardiorenal applications, while identifying gaps in long-term safety and dialysis dosing.
www.synapsesocial.com/papers/69d895486c1944d70ce06428 — DOI: https://doi.org/10.1080/0886022x.2026.2644751